Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Pacific Biosciences of California Inc

PACB ✗ NOT COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Advanced Medical Equipment & Technology ·

USA Small Cap Analyst: BUY

Last Close

$1.52

▲ +18.75%

Market Cap $472.46M · Vol 2.67M

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$472.46M

Small Cap

Div Yield

N/A

EPS Growth

+4.19%

YoY

RSI (14)

61.00

Momentum

Beta

2.32

vs Market

52W High

$2.73

44.22% below

52W Low

$1.08

41.40% above

Volume

2.67M

Avg 1.22M

P/B

105.56

Price-to-book

ROE

-61.87%

Return on equity

Free Float

90.99%

Public shares

Shariah Compliance8 STANDARDS

✗ Pacific Biosciences of California Inc (PACB) stock is currently not Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See which standards it fails, the exact ratios behind the verdict, and halal alternatives. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does PACB pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+33.33%

+11.76%

+24.59%

-6.75%

YTD

-18.72%

+15.15%

-84.68%

-94.77%

Financials & Valuation

TTM · Annual

Total Revenue	$160.01M
Net Income	$-546,376,000.00
Revenue Growth (YoY)	-1.91%
Gross Margin	27.95%
Operating Margin	-108.74%
Net Profit Margin	-341.47%
ROE	-61.87%
ROA · ROIC	-53.42% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	3.51
P/B	105.56
P/FCF	N/A
EPS Growth	+4.19%
Outstanding Shares	310.83M

Technical Indicators

50-Day SMA	$1.40
200-Day SMA	$1.65
RSI (14)	61.00
Beta	2.32
52-Week High	$2.73
52-Week Low	$1.08

Volume Today	2.67M
Avg Daily Volume (30D)	1.22M
Relative Volume	2.20x
Volatility (10D)	115.70
Volatility (30D)	91.42
Free Float	90.99%

Analyst Consensus

BUY

Current Price $1.52

Mean Target $2.29

52W Low$1.08 52W High$2.73

Current

Target

$1.08 $2.73

Current Analyst target

+50.77% upside potential · 7 analysts

Identifiers

ExchangeNasdaq

FIGIBBG001SS9G64

ISINUS69404D1081

CountryUnited States of America

Sub-IndustryAdvanced Medical Equipment & Technology (NEC)

Earnings DateNov 3, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

TMO Thermo Fisher Scientific Inc -0.09% DHR Danaher Corp +0.40% ISRG Intuitive Surgical Inc -0.46% BSX Boston Scientific Corp +1.73% EW Edwards Lifesciences Corp +0.41%

Company Profile

Pacific Biosciences of California, Inc. is a life science technology company. The Company designs, develops, and manufactures sequencing solutions. Its products and technology include HiFi long-read sequencing technology, which addresses a set of applications including human germline sequencing, plant and animal sciences, infectious disease, microbiology, oncology, and other applications. Its sequencing technology supports oncology research by enabling analysis of both deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), providing researchers with insight into cancer biology. It focuses on creating sequencing systems to provide customers with a view of genomes, transcriptomes, and epigenomes. Its customers include academic and governmental research institutions, commercial testing and service laboratories, genome centers, public health labs, hospitals and clinical research institutes, contract research organizations (CROs), pharmaceutical companies, and agricultural companies.